{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T15:56:40Z","timestamp":1794412600983,"version":"4.9.0"},"reference-count":143,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"DOI":"10.3389\/fmed.2015.00072","type":"journal-article","created":{"date-parts":[[2015,10,8]],"date-time":"2015-10-08T08:40:58Z","timestamp":1444293658000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":33,"title":["Targeted Therapies in Liver Fibrosis: Combining the Best Parts of Platelet-Derived Growth Factor BB and Interferon Gamma"],"prefix":"10.3389","volume":"2","author":[{"given":"Fransien","family":"van Dijk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Olinga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaas","family":"Poelstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonie","family":"Beljaars","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2015,10,5]]},"reference":[{"issue":"Suppl 4","key":"B1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1634\/theoncologist.2010-S4-05","article-title":"The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective","volume":"15","author":"Venook","year":"2010","journal-title":"Oncologist"},{"issue":"1 Suppl","key":"B2","doi-asserted-by":"publisher","first-page":"S144","DOI":"10.1016\/j.jhep.2015.02.007","article-title":"Liver cancer: approaching a personalized care","volume":"62","author":"Bruix","year":"2015","journal-title":"J Hepatol"},{"issue":"1","key":"B3","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1152\/physrev.00013.2007","article-title":"Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver","volume":"88","author":"Friedman","year":"2007","journal-title":"Physiol Rev"},{"issue":"1S","key":"B4","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1016\/j.jhep.2015.02.039","article-title":"Hepatic fibrosis: concept to treatment","volume":"62","author":"Trautwein","year":"2015","journal-title":"J Hepatol"},{"issue":"3","key":"B5","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1055\/s-0030-1255354","article-title":"Macrophages: master regulators of inflammation and fibrosis","volume":"30","author":"Wynn","year":"2010","journal-title":"Semin Liver Dis"},{"issue":"4","key":"B6","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1002\/hep.24190","article-title":"Suppression of innate immunity (natural killer cell\/interferon-gamma) in the advanced stages of liver fibrosis in mice","volume":"53","author":"Jeong","year":"2011","journal-title":"Hepatology"},{"issue":"3","key":"B7","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1002\/hep.27332","article-title":"Hepatic inflammation and fibrosis: functional links and key pathways","volume":"61","author":"Seki","year":"2015","journal-title":"Hepatology"},{"issue":"3","key":"B8","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/nri3623","article-title":"Liver fibrosis and repair: immune regulation of wound healing in a solid organ","volume":"14","author":"Pellicoro","year":"2014","journal-title":"Nat Rev Immunol"},{"issue":"7","key":"B9","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1016\/S0006-2952(03)00445-3","article-title":"The preferential homing of a platelet derived growth factor receptor-recognizing macromolecule to fibroblast-like cells in fibrotic tissue","volume":"66","author":"Beljaars","year":"2003","journal-title":"Biochem Pharmacol"},{"issue":"12","key":"B10","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1097\/00042737-199812000-00009","article-title":"Transforming growth factor betas and their receptors in human liver cirrhosis","volume":"10","author":"Baer","year":"1998","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"3","key":"B11","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1002\/hep.1840210325","article-title":"Transforming growth factor-beta 1 (TGF-beta 1) and TGF-beta 1 receptors in normal, cirrhotic, and neoplastic human livers","volume":"21","author":"Bedossa","year":"1995","journal-title":"Hepatology"},{"issue":"10","key":"B12","doi-asserted-by":"publisher","first-page":"6553","DOI":"10.4049\/jimmunol.180.10.6553","article-title":"Activation of a TGF-beta-specific multistep gene expression program in mature macrophages requires glucocorticoid-mediated surface expression of TGF-beta receptor II","volume":"180","author":"Gratchev","year":"2008","journal-title":"J Immunol"},{"issue":"9","key":"B13","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1111\/j.1478-3231.2006.01339.x","article-title":"How to modulate inflammatory cytokines in liver diseases","volume":"26","author":"Tilg","year":"2006","journal-title":"Liver Int"},{"issue":"2","key":"B14","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1189\/jlb.0603252","article-title":"Interferon-gamma: an overview of signals, mechanisms and functions","volume":"75","author":"Schroder","year":"2004","journal-title":"J Leukoc Biol"},{"issue":"3","key":"B15","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1073\/pnas.68.3.645","article-title":"Serum factor requirements of normal and simian virus 40-transformed 3T3 mouse fibroplasts","volume":"68","author":"Paul","year":"1971","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"B16","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1172\/JCI114363","article-title":"Effects of platelet-derived growth factor and other polypeptide mitogens on DNA synthesis and growth of cultured rat liver fat-storing cells","volume":"84","author":"Pinzani","year":"1989","journal-title":"J Clin Invest"},{"issue":"3","key":"B17","first-page":"785","article-title":"Expression of platelet-derived growth factor and its receptors in normal human liver and during active hepatic fibrogenesis","volume":"148","author":"Pinzani","year":"1996","journal-title":"Am J Pathol"},{"issue":"4","key":"B18","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1002\/bdrc.10030","article-title":"Biology of platelet-derived growth factors in development","volume":"69","author":"Betsholtz","year":"2003","journal-title":"Birth Defects Res C Embryo Today"},{"issue":"4","key":"B19","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1152\/physrev.1999.79.4.1283","article-title":"Mechanism of action and in vivo role of platelet-derived growth factor","volume":"79","author":"Heldin","year":"1999","journal-title":"Physiol Rev"},{"issue":"22","key":"B20","doi-asserted-by":"publisher","first-page":"5723","DOI":"10.1111\/j.1742-4658.2005.04989.x","article-title":"Structural and functional specificities of PDGF-C and PDGF-D, the novel members of the platelet-derived growth factors family","volume":"272","author":"Reigstad","year":"2005","journal-title":"FEBS J"},{"issue":"6","key":"B21","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.yexcr.2005.11.035","article-title":"Nuclear localisation of endogenous SUMO-1-modified PDGF-C in human thyroid tissue and cell lines","volume":"312","author":"Reigstad","year":"2006","journal-title":"Exp Cell Res"},{"issue":"13","key":"B22","doi-asserted-by":"crossref","first-page":"9621","DOI":"10.1016\/S0021-9258(18)98395-X","article-title":"Identification of a soluble receptor for platelet-derived growth factor in cell-conditioned medium and human plasma","volume":"268","author":"Tiesman","year":"1993","journal-title":"J Biol Chem"},{"issue":"7","key":"B23","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1111\/j.1440-1746.2008.05729.x","article-title":"Effects of lipopolysaccharide on platelet-derived growth factor isoform and receptor expression in cultured rat common bile duct fibroblasts and cholangiocytes","volume":"24","author":"Kim","year":"2009","journal-title":"J Gastroenterol Hepatol"},{"issue":"2","key":"B24","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1002\/hep.24395","article-title":"Novel engineered targeted interferon-gamma blocks hepatic fibrogenesis in mice","volume":"54","author":"Bansal","year":"2011","journal-title":"Hepatology"},{"issue":"1","key":"B25","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1083\/jcb.201007003","article-title":"Integrins traffic rapidly via circular dorsal ruffles and macropinocytosis during stimulated cell migration","volume":"193","author":"Gu","year":"2011","journal-title":"J Cell Biol"},{"issue":"11","key":"B26","doi-asserted-by":"publisher","first-page":"G1033","DOI":"10.1152\/ajpgi.00151.2014","article-title":"PDGF-BB and bFGF ameliorate radiation-induced intestinal progenitor\/stem cell apoptosis via akt\/p53 signaling in mice","volume":"307","author":"Liu","year":"2014","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"2","key":"B27","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1182\/blood.V64.2.458.458","article-title":"Platelet-derived growth factor in vivo: levels, activity, and rate of clearance","volume":"64","author":"Bowen-Pope","year":"1984","journal-title":"Blood"},{"issue":"3","key":"B28","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1080\/03008200802148702","article-title":"Glycosaminoglycans and PDGF signaling in mesenchymal cells","volume":"49","author":"Zafiropoulos","year":"2008","journal-title":"Connect Tissue Res"},{"issue":"8","key":"B29","doi-asserted-by":"publisher","first-page":"5826","DOI":"10.1074\/jbc.275.8.5826","article-title":"Identical or overlapping sequences in the primary structure of human alpha(2)-macroglobulin are responsible for the binding of nerve growth factor-beta, platelet-derived growth factor-BB, and transforming growth factor-beta","volume":"275","author":"Gonias","year":"2000","journal-title":"J Biol Chem"},{"issue":"10","key":"B30","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1038\/labinvest.2008.71","article-title":"Platelet-derived growth factor isoform expression in carbon tetrachloride-induced chronic liver injury","volume":"88","author":"Borkham-Kamphorst","year":"2008","journal-title":"Lab Invest"},{"issue":"13","key":"B31","doi-asserted-by":"crossref","first-page":"4113","DOI":"10.1002\/j.1460-2075.1991.tb04988.x","article-title":"Two PDGF-B chain residues, arginine 27 and isoleucine 30, mediate receptor binding and activation","volume":"10","author":"Clements","year":"1991","journal-title":"EMBO J"},{"issue":"14","key":"B32","doi-asserted-by":"crossref","first-page":"10482","DOI":"10.1016\/S0021-9258(18)82224-4","article-title":"A cationic region of the platelet-derived growth factor (PDGF) A-chain (Arg159-Lys160-Lys161) is required for receptor binding and mitogenic activity of the PDGF-AA homodimer","volume":"268","author":"Fenstermaker","year":"1993","journal-title":"J Biol Chem"},{"issue":"10","key":"B33","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1016\/j.bbapap.2012.10.015","article-title":"Platelet-derived growth factors and their receptors: structural and functional perspectives","volume":"1834","author":"Chen","year":"2013","journal-title":"Biochim Biophys Acta"},{"issue":"22","key":"B34","doi-asserted-by":"publisher","first-page":"7681","DOI":"10.1073\/pnas.0802896105","article-title":"Contacts between membrane proximal regions of the PDGF receptor ectodomain are required for receptor activation but not for receptor dimerization","volume":"105","author":"Yang","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B35","doi-asserted-by":"publisher","first-page":"d1720","DOI":"10.2741\/pinzani","article-title":"PDGF and signal transduction in hepatic stellate cells","volume":"7","author":"Pinzani","year":"2002","journal-title":"Front Biosci"},{"issue":"2","key":"B36","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1002\/jcp.1041560221","article-title":"Pool of ligand-bound platelet-derived growth factor beta-receptors remain activated and tyrosine phosphorylated after internalization","volume":"156","author":"Sorkin","year":"1993","journal-title":"J Cell Physiol"},{"issue":"17","key":"B37","doi-asserted-by":"publisher","first-page":"10299","DOI":"10.1074\/jbc.271.17.10299","article-title":"Localization of platelet-derived growth factor-stimulated phosphorylation cascade to caveolae","volume":"271","author":"Liu","year":"1996","journal-title":"J Biol Chem"},{"issue":"25","key":"B38","doi-asserted-by":"publisher","first-page":"13666","DOI":"10.1073\/pnas.94.25.13666","article-title":"Platelet-derived growth factor activates mitogen-activated protein kinase in isolated caveolae","volume":"94","author":"Liu","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6\u20137","key":"B39","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.biochi.2007.03.014","article-title":"Interfering with interferon receptor sorting and trafficking: impact on signaling","volume":"89","author":"Claudinon","year":"2007","journal-title":"Biochimie"},{"issue":"5560","key":"B40","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1126\/science.1070127","article-title":"A pit stop at the ER","volume":"295","author":"Gill","year":"2002","journal-title":"Science"},{"issue":"5","key":"B41","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1089\/jir.1987.7.429","article-title":"Virus interference. I. The interferon. By A. Isaacs and J. Lindenmann, 1957","volume":"7","author":"Isaacs","year":"1987","journal-title":"J Interferon Res"},{"issue":"2","key":"B42","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1073\/pnas.76.2.640","article-title":"Human leukocyte interferon: production, purification to homogeneity, and initial characterization","volume":"76","author":"Rubinstein","year":"1979","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"B43","doi-asserted-by":"publisher","first-page":"5601","DOI":"10.1073\/pnas.76.11.5601","article-title":"Purification and partial characterization of human lymphoblast interferon","volume":"76","author":"Zoon","year":"1979","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"B44","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/jps.10007","article-title":"Interferon-gamma therapy: evaluation of routes of administration and delivery systems","volume":"91","author":"Younes","year":"2002","journal-title":"J Pharm Sci"},{"key":"B45","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1146\/annurev.immunol.15.1.563","article-title":"The IFN gamma receptor: a paradigm for cytokine receptor signaling","volume":"15","author":"Bach","year":"1997","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"B46","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/0163-7258(90)90012-Q","article-title":"Interferon-gamma: producer cells, activation stimuli, and molecular genetic regulation","volume":"45","author":"Young","year":"1990","journal-title":"Pharmacol Ther"},{"key":"B47","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1146\/annurev.iy.11.040193.003035","article-title":"The molecular cell biology of interferon-gamma and its receptor","volume":"11","author":"Farrar","year":"1993","journal-title":"Annu Rev Immunol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S0065-2776(08)60428-9","article-title":"Interferon-gamma: biology and role in pathogenesis","volume":"62","author":"Billiau","year":"1996","journal-title":"Adv Immunol"},{"issue":"5849","key":"B49","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/295503a0","article-title":"Expression of human immune interferon cDNA in E. coli and monkey cells","volume":"295","author":"Gray","year":"1982","journal-title":"Nature"},{"issue":"19","key":"B50","doi-asserted-by":"publisher","first-page":"5842","DOI":"10.1073\/pnas.80.19.5842","article-title":"Cloning and expression of murine immune interferon cDNA","volume":"80","author":"Gray","year":"1983","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"B51","doi-asserted-by":"crossref","first-page":"4301","DOI":"10.1016\/S0021-9258(17)43045-6","article-title":"Three molecular weight forms of natural human interferon-gamma revealed by immunoprecipitation with monoclonal antibody","volume":"259","author":"Kelker","year":"1984","journal-title":"J Biol Chem"},{"issue":"9","key":"B52","doi-asserted-by":"crossref","first-page":"4647","DOI":"10.4049\/jimmunol.163.9.4647","article-title":"Cutting edge: cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells","volume":"163","author":"Carnaud","year":"1999","journal-title":"J Immunol"},{"issue":"10","key":"B53","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/S1471-4906(01)02005-1","article-title":"IFN-gamma production by antigen-presenting cells: mechanisms emerge","volume":"22","author":"Frucht","year":"2001","journal-title":"Trends Immunol"},{"issue":"2","key":"B54","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S1359-6101(98)00007-0","article-title":"IFN-gamma expression in macrophages and its possible biological significance","volume":"9","author":"Gessani","year":"1998","journal-title":"Cytokine Growth Factor Rev"},{"issue":"7","key":"B55","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.4049\/jimmunol.161.7.3400","article-title":"IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFN-gamma production","volume":"161","author":"Yoshimoto","year":"1998","journal-title":"J Immunol"},{"issue":"9","key":"B56","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1084\/jem.192.9.1381","article-title":"Autocrine secretion of interferon gamma negatively regulates homing of immature B cells","volume":"192","author":"Flaishon","year":"2000","journal-title":"J Exp Med"},{"issue":"6","key":"B57","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/82717","article-title":"Reciprocal regulation of polarized cytokine production by effector B and T cells","volume":"1","author":"Harris","year":"2000","journal-title":"Nat Immunol"},{"issue":"10","key":"B58","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1001\/jama.1991.03470100067035","article-title":"The interferons. Mechanisms of action and clinical applications","volume":"266","author":"Baron","year":"1991","journal-title":"JAMA"},{"issue":"1","key":"B59","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1136\/gut.2010.211136","article-title":"Amelioration of hepatic fibrosis by NK cell activation","volume":"60","author":"Muhanna","year":"2011","journal-title":"Gut"},{"issue":"2","key":"B60","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1053\/j.gastro.2005.10.055","article-title":"Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners","volume":"130","author":"Radaeva","year":"2006","journal-title":"Gastroenterology"},{"issue":"1","key":"B61","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jhep.2005.12.025","article-title":"Anti-fibrotic activity of NK cells in experimental liver injury through killing of activated HSC","volume":"45","author":"Melhem","year":"2006","journal-title":"J Hepatol"},{"issue":"5","key":"B62","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1002\/hep.510230538","article-title":"Interferon gamma decreases hepatic stellate cell activation and extracellular matrix deposition in rat liver fibrosis","volume":"23","author":"Baroni","year":"1996","journal-title":"Hepatology"},{"issue":"4","key":"B63","first-page":"660","article-title":"Interferon gamma inhibits lipocyte activation and extracellular matrix mRNA expression during experimental liver injury: implications for treatment of hepatic fibrosis","volume":"42","author":"Rockey","year":"1994","journal-title":"J Investig Med"},{"issue":"6","key":"B64","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1002\/hep.21419","article-title":"STAT1 inhibits liver fibrosis in mice by inhibiting stellate cell proliferation and stimulating NK cell cytotoxicity","volume":"44","author":"Jeong","year":"2006","journal-title":"Hepatology"},{"key":"B65","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1146\/annurev.bi.59.070190.004031","article-title":"Cytokines: coordinators of immune and inflammatory responses","volume":"59","author":"Arai","year":"1990","journal-title":"Annu Rev Biochem"},{"key":"B66","doi-asserted-by":"publisher","first-page":"453","DOI":"10.2741\/2692","article-title":"Macrophage activation and polarization","volume":"13","author":"Martinez","year":"2008","journal-title":"Front Biosci"},{"issue":"1","key":"B67","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1053\/j.gastro.2007.09.034","article-title":"Abrogation of the antifibrotic effects of natural killer cells\/interferon-gamma contributes to alcohol acceleration of liver fibrosis","volume":"134","author":"Jeong","year":"2008","journal-title":"Gastroenterology"},{"issue":"6721","key":"B68","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1038\/17826","article-title":"Inhibition of transforming growth factor-beta\/SMAD signalling by the interferon-gamma\/STAT pathway","volume":"397","author":"Ulloa","year":"1999","journal-title":"Nature"},{"issue":"7","key":"B69","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/j.1460-2075.1994.tb06422.x","article-title":"Ligand-induced IFN gamma receptor tyrosine phosphorylation couples the receptor to its signal transduction system (p91)","volume":"13","author":"Greenlund","year":"1994","journal-title":"EMBO J"},{"issue":"6","key":"B70","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1189\/jlb.70.6.950","article-title":"Interferon-gamma receptor 2 expression as the deciding factor in human T, B, and myeloid cell proliferation or death","volume":"70","author":"Bernabei","year":"2001","journal-title":"J Leukoc Biol"},{"issue":"6220","key":"B71","doi-asserted-by":"publisher","first-page":"1260419","DOI":"10.1126\/science.1260419","article-title":"Proteomics. Tissue-based map of the human proteome","volume":"347","author":"Uhl\u00e9n","year":"2015","journal-title":"Science"},{"issue":"3","key":"B72","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.jconrel.2011.05.027","article-title":"PEGylation improves pharmacokinetic profile, liver uptake and efficacy of interferon gamma in liver fibrosis","volume":"154","author":"Bansal","year":"2011","journal-title":"J Control Release"},{"issue":"4","key":"B73","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/j.1460-2075.1996.tb00415.x","article-title":"Kinase-negative mutants of JAK1 can sustain interferon-gamma-inducible gene expression but not an antiviral state","volume":"15","author":"Briscoe","year":"1996","journal-title":"EMBO J"},{"issue":"6","key":"B74","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/1074-7613(95)90012-8","article-title":"Stat recruitment by tyrosine-phosphorylated cytokine receptors: an ordered reversible affinity-driven process","volume":"2","author":"Greenlund","year":"1995","journal-title":"Immunity"},{"issue":"5202","key":"B75","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1126\/science.7871432","article-title":"Contribution of STAT SH2 groups to specific interferon signaling by the Jak-STAT pathway","volume":"267","author":"Heim","year":"1995","journal-title":"Science"},{"issue":"20","key":"B76","doi-asserted-by":"crossref","first-page":"14333","DOI":"10.1016\/S0021-9258(17)36621-8","article-title":"Interferon-gamma induces tyrosine phosphorylation of interferon-gamma receptor and regulated association of protein tyrosine kinases, Jak1 and Jak2, with its receptor","volume":"269","author":"Igarashi","year":"1994","journal-title":"J Biol Chem"},{"issue":"5164","key":"B77","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1126\/science.8197455","article-title":"Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins","volume":"264","author":"Darnell","year":"1994","journal-title":"Science"},{"key":"B78","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1146\/annurev.bi.64.070195.003201","article-title":"Transcriptional responses to polypeptide ligands: the JAK-STAT pathway","volume":"64","author":"Schindler","year":"1995","journal-title":"Annu Rev Biochem"},{"issue":"21","key":"B79","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1038\/sj.onc.1203525","article-title":"Complex roles of Stat1 in regulating gene expression","volume":"19","author":"Ramana","year":"2000","journal-title":"Oncogene"},{"issue":"2","key":"B80","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/0014-5793(91)80802-A","article-title":"The control of interferon-inducible gene expression","volume":"285","author":"Kerr","year":"1991","journal-title":"FEBS Lett"},{"key":"B81","doi-asserted-by":"publisher","first-page":"202","DOI":"10.3389\/fimmu.2013.00202","article-title":"IFN signaling: how a non-canonical model led to the development of IFN mimetics","volume":"4","author":"Johnson","year":"2013","journal-title":"Front Immunol"},{"issue":"6","key":"B82","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1515\/BC.1999.087","article-title":"Activation of the transcription factor ISGF3 by interferon-gamma","volume":"380","author":"Matsumoto","year":"1999","journal-title":"Biol Chem"},{"key":"B83","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1146\/annurev.biochem.67.1.227","article-title":"How cells respond to interferons","volume":"67","author":"Stark","year":"1998","journal-title":"Annu Rev Biochem"},{"issue":"1","key":"B84","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/1359-6101(96)00005-6","article-title":"ISGF3 gamma p48, a specificity switch for interferon activated transcription factors","volume":"7","author":"Bluyssen","year":"1996","journal-title":"Cytokine Growth Factor Rev"},{"issue":"5\u20136","key":"B85","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.cytogfr.2008.08.004","article-title":"IFNgamma signaling-does it mean JAK-STAT?","volume":"19","author":"Gough","year":"2008","journal-title":"Cytokine Growth Factor Rev"},{"issue":"7265","key":"B86","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1038\/nature08448","article-title":"JAK2 phosphorylates histone H3Y41 and excludes HP1alpha from chromatin","volume":"461","author":"Dawson","year":"2009","journal-title":"Nature"},{"issue":"4","key":"B87","doi-asserted-by":"publisher","first-page":"e26227","DOI":"10.4161\/jkst.26227","article-title":"The role of a non-canonical JAK-STAT pathway in IFN therapy of poxvirus infection and multiple sclerosis: an example of Occam\u2019s Broom?","volume":"2","author":"Ahmed","year":"2013","journal-title":"JAKSTAT"},{"issue":"8","key":"B88","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1038\/nri1885","article-title":"Tracking STAT nuclear traffic","volume":"6","author":"Reich","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1146\/annurev.cellbio.17.1.517","article-title":"Biological basket weaving: formation and function of clathrin-coated vesicles","volume":"17","author":"Brodsky","year":"2001","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"10","key":"B90","doi-asserted-by":"crossref","first-page":"3436","DOI":"10.4049\/jimmunol.142.10.3436","article-title":"Binding and internalization of gold-labeled IFN-gamma by human Raji cells","volume":"142","author":"Filgueira","year":"1989","journal-title":"J Immunol"},{"issue":"4","key":"B91","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/S0092-8674(04)00167-9","article-title":"Nanoscale organization of multiple GPI-anchored proteins in living cell membranes","volume":"116","author":"Sharma","year":"2004","journal-title":"Cell"},{"issue":"5475","key":"B92","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1126\/science.288.5475.2357","article-title":"Cross talk between interferon-gamma and -alpha\/beta signaling components in caveolar membrane domains","volume":"288","author":"Takaoka","year":"2000","journal-title":"Science"},{"issue":"3","key":"B93","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1002\/mrd.1094","article-title":"Mouse oocytes and preimplantation embryos bear the two sub-units of interferon-gamma receptor","volume":"60","author":"Truchet","year":"2001","journal-title":"Mol Reprod Dev"},{"issue":"4","key":"B94","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.4049\/jimmunol.169.4.1959","article-title":"Lipid microdomains are required sites for the selective endocytosis and nuclear translocation of IFN-gamma, its receptor chain IFN-gamma receptor-1, and the phosphorylation and nuclear translocation of STAT1alpha","volume":"169","author":"Subramaniam","year":"2002","journal-title":"J Immunol"},{"issue":"1","key":"B95","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1006\/cyto.2000.0854","article-title":"Caveolae and clathrin-coated vesicles: two possible internalization pathways for IFN-gamma and IFN-gamma receptor","volume":"14","author":"Sadir","year":"2001","journal-title":"Cytokine"},{"issue":"29","key":"B96","doi-asserted-by":"crossref","first-page":"19626","DOI":"10.1016\/S0021-9258(18)55039-0","article-title":"Identification of two regions within the cytoplasmic domain of the human interferon-gamma receptor required for function","volume":"266","author":"Farrar","year":"1991","journal-title":"J Biol Chem"},{"issue":"20","key":"B97","doi-asserted-by":"crossref","first-page":"11981","DOI":"10.1016\/S0021-9258(18)80163-6","article-title":"Biosynthetic analysis of the human interferon-gamma receptor. Identification of N-linked glycosylation intermediates","volume":"264","author":"Hershey","year":"1989","journal-title":"J Biol Chem"},{"issue":"10","key":"B98","doi-asserted-by":"crossref","first-page":"6497","DOI":"10.1016\/S0021-9258(18)32439-6","article-title":"Human interferon-gamma is internalized and degraded by cultured fibroblasts","volume":"258","author":"Anderson","year":"1983","journal-title":"J Biol Chem"},{"issue":"1","key":"B99","doi-asserted-by":"crossref","first-page":"147","DOI":"10.4049\/jimmunol.139.1.147","article-title":"Internalization and degradation of receptor-bound interferon-gamma by murine macrophages. Demonstration of receptor recycling","volume":"139","author":"Celada","year":"1987","journal-title":"J Immunol"},{"issue":"1","key":"B100","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/0090-1229(88)90148-1","article-title":"Internalization and degradation of human recombinant interferon-gamma in the human histiocytic lymphoma cell line, U937: relationship to Fc receptor enhancement and antiproliferation","volume":"47","author":"Finbloom","year":"1988","journal-title":"Clin Immunol Immunopathol"},{"issue":"1","key":"B101","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1006\/bbrc.1994.1691","article-title":"Binding of IFN gamma and its C-terminal peptide to a cytoplasmic domain of its receptor that is essential for function","volume":"201","author":"Szente","year":"1994","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"B102","doi-asserted-by":"publisher","first-page":"315","DOI":"10.4049\/jimmunol.177.1.315","article-title":"IFN-gamma and its receptor subunit IFNGR1 are recruited to the IFN-gamma-activated sequence element at the promoter site of IFN-gamma-activated genes: evidence of transactivational activity in IFNGR1","volume":"177","author":"Ahmed","year":"2006","journal-title":"J Immunol"},{"issue":"8","key":"B103","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1128\/CVI.00021-06","article-title":"The gamma interferon (IFN-gamma) mimetic peptide IFN-gamma (95-133) prevents encephalomyocarditis virus infection both in tissue culture and in mice","volume":"13","author":"Mujtaba","year":"2006","journal-title":"Clin Vaccine Immunol"},{"issue":"3","key":"B104","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1006\/bbrc.1998.9831","article-title":"Unrestricted agonist activity on murine and human cells of a lipopeptide derived from IFN-gamma","volume":"253","author":"Thiam","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"issue":"12","key":"B105","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.4155\/fmc.12.94","article-title":"Therapeutic peptides","volume":"4","author":"Albericio","year":"2012","journal-title":"Future Med Chem"},{"key":"B106","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jconrel.2014.01.022","article-title":"Interferon gamma peptidomimetic targeted to hepatic stellate cells ameliorates acute and chronic liver fibrosis in vivo","volume":"179","author":"Bansal","year":"2014","journal-title":"J Control Release"},{"issue":"2","key":"B107","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1055\/s-0035-1550057","article-title":"Resolution of liver fibrosis: basic mechanisms and clinical relevance","volume":"35","author":"Ramachandran","year":"2015","journal-title":"Semin Liver Dis"},{"issue":"5","key":"B108","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1172\/JCI66028","article-title":"Evolving therapies for liver fibrosis","volume":"123","author":"Schuppan","year":"2013","journal-title":"J Clin Invest"},{"issue":"Suppl(1)","key":"B109","doi-asserted-by":"publisher","first-page":"S22","DOI":"10.1016\/j.jhep.2004.12.008","article-title":"Fibrosis in chronic liver diseases: diagnosis and management","volume":"42","author":"Pinzani","year":"2005","journal-title":"J Hepatol"},{"issue":"2","key":"B110","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1055\/s-0035-1550055","article-title":"Antifibrotic therapies in the liver","volume":"35","author":"Mehal","year":"2015","journal-title":"Semin Liver Dis"},{"issue":"3","key":"B111","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1517\/13543784.2015.997874","article-title":"Early to phase II drugs currently under investigation for the treatment of liver fibrosis","volume":"24","author":"Hauff","year":"2015","journal-title":"Expert Opin Investig Drugs"},{"issue":"167","key":"B112","doi-asserted-by":"publisher","first-page":"167sr1","DOI":"10.1126\/scitranslmed.3004700","article-title":"Therapy for fibrotic diseases: nearing the starting line","volume":"5","author":"Friedman","year":"2013","journal-title":"Sci Transl Med"},{"issue":"5","key":"B113","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1111\/j.1365-2893.2005.00689.x","article-title":"Interferon gamma-1b for the treatment of fibrosis in chronic hepatitis C infection","volume":"13","author":"Muir","year":"2006","journal-title":"J Viral Hepat"},{"issue":"1","key":"B114","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jhep.2005.02.023","article-title":"Pilot study of interferon gamma for chronic hepatitis C","volume":"43","author":"Soza","year":"2005","journal-title":"J Hepatol"},{"issue":"2","key":"B115","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.bbrc.2004.06.153","article-title":"Antisense strategy against PDGF B-chain proves effective in preventing experimental liver fibrogenesis","volume":"321","author":"Borkham-Kamphorst","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"issue":"11","key":"B116","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1111\/j.1872-034X.2010.00718.x","article-title":"Anti-PDGF-B monoclonal antibody reduces liver fibrosis development","volume":"40","author":"Ogawa","year":"2010","journal-title":"Hepatol Res"},{"issue":"10","key":"B117","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1111\/j.1478-3231.2008.01759.x","article-title":"RNA interference targeting the platelet-derived growth factor receptor beta subunit ameliorates experimental hepatic fibrosis in rats","volume":"28","author":"Chen","year":"2008","journal-title":"Liver Int"},{"issue":"21","key":"B118","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1038\/gt.2008.93","article-title":"Targeted inhibition of platelet-derived growth factor receptor-beta subunit in hepatic stellate cells ameliorates hepatic fibrosis in rats","volume":"15","author":"Chen","year":"2008","journal-title":"Gene Ther"},{"issue":"1","key":"B119","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jhep.2005.06.015","article-title":"Oral imatinib treatment reduces early fibrogenesis but does not prevent progression in the long term","volume":"44","author":"Neef","year":"2006","journal-title":"J Hepatol"},{"issue":"1","key":"B120","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s10620-012-2325-y","article-title":"Antifibrotic activity of sorafenib in experimental hepatic fibrosis: refinement of inhibitory targets, dosing, and window of efficacy in vivo","volume":"58","author":"Hong","year":"2013","journal-title":"Dig Dis Sci"},{"issue":"3","key":"B121","doi-asserted-by":"publisher","first-page":"742","DOI":"10.3748\/wjg.v21.i3.742","article-title":"Use of mesenchymal stem cells to treat liver fibrosis: current situation and future prospects","volume":"21","author":"Berardis","year":"2015","journal-title":"World J Gastroenterol"},{"issue":"23\u201324","key":"B122","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1016\/j.drudis.2013.05.013","article-title":"Cell-specific delivery of biologicals: problems, pitfalls and possibilities of antifibrotic compounds in the liver","volume":"18","author":"Poelstra","year":"2013","journal-title":"Drug Discov Today"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27936","article-title":"Specific hepatic delivery of procollagen alpha1(I) siRNA in lipid-like nanoparticles resolves liver fibrosis","author":"Jim\u00e9nez Calvente","year":"2015","journal-title":"Hepatology"},{"issue":"6","key":"B124","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/j.jhep.2005.01.028","article-title":"Generation of a monoclonal human single chain antibody fragment to hepatic stellate cells \u2013 a potential mechanism for targeting liver anti-fibrotic therapeutics","volume":"42","author":"Elrick","year":"2005","journal-title":"J Hepatol"},{"issue":"5","key":"B125","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1002\/hep.510290526","article-title":"Albumin modified with mannose 6-phosphate: a potential carrier for selective delivery of antifibrotic drugs to rat and human hepatic stellate cells","volume":"29","author":"Beljaars","year":"1999","journal-title":"Hepatology"},{"issue":"17","key":"B126","doi-asserted-by":"publisher","first-page":"12743","DOI":"10.1074\/jbc.275.17.12743","article-title":"Successful targeting to rat hepatic stellate cells using albumin modified with cyclic peptides that recognize the collagen type VI receptor","volume":"275","author":"Beljaars","year":"2000","journal-title":"J Biol Chem"},{"issue":"2","key":"B127","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.jconrel.2011.06.037","article-title":"Targeted TFO delivery to hepatic stellate cells","volume":"155","author":"Yang","year":"2011","journal-title":"J Control Release"},{"issue":"2","key":"B128","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.jconrel.2011.12.023","article-title":"Effects of interferon-gamma liposomes targeted to platelet-derived growth factor receptor-beta on hepatic fibrosis in rats","volume":"159","author":"Li","year":"2012","journal-title":"J Control Release"},{"issue":"6","key":"B129","doi-asserted-by":"publisher","first-page":"364","DOI":"10.3978\/j.issn.2304-3881.2014.11.02","article-title":"Therapeutic targeting of liver inflammation and fibrosis by nanomedicine","volume":"3","author":"Bartneck","year":"2014","journal-title":"Hepatobiliary Surg Nutr"},{"issue":"3","key":"B130","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/nbt0395-265","article-title":"Phage libraries displaying cyclic peptides with different ring sizes: ligand specificities of the RGD-directed integrins","volume":"13","author":"Koivunen","year":"1995","journal-title":"Biotechnology (N Y)"},{"issue":"2","key":"B131","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/0167-4838(95)00026-Q","article-title":"Attachment of articular cartilage chondrocytes to the tissue form of type VI collagen","volume":"1249","author":"Marcelino","year":"1995","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"B132","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.1016\/S0021-9258(18)53739-X","article-title":"Mechanism of platelet-derived growth factor (PDGF) AA, AB, and BB binding to alpha and beta PDGF receptor","volume":"268","author":"Fretto","year":"1993","journal-title":"J Biol Chem"},{"issue":"5","key":"B133","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1021\/mp200263q","article-title":"Peptide-modified albumin carrier explored as a novel strategy for a cell-specific delivery of interferon gamma to treat liver fibrosis","volume":"8","author":"Bansal","year":"2011","journal-title":"Mol Pharm"},{"issue":"3","key":"B134","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1007\/s11095-006-9175-2","article-title":"Targeting 15d-prostaglandin J2 to hepatic stellate cells: two options evaluated","volume":"24","author":"Hagens","year":"2007","journal-title":"Pharm Res"},{"issue":"3","key":"B135","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1096\/fj.14-258459","article-title":"Selective delivery of IFN-gamma to renal interstitial myofibroblasts: a novel strategy for the treatment of renal fibrosis","volume":"29","author":"Poosti","year":"2015","journal-title":"FASEB J"},{"issue":"18","key":"B136","doi-asserted-by":"publisher","first-page":"5445","DOI":"10.1021\/bi036213t","article-title":"Signal transduction mechanism of a peptide mimetic of interferon-gamma","volume":"43","author":"Subramaniam","year":"2004","journal-title":"Biochemistry"},{"issue":"3","key":"B137","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1006\/bbrc.1994.2375","article-title":"The C-terminus of IFN gamma is sufficient for intracellular function","volume":"203","author":"Szente","year":"1994","journal-title":"Biochem Biophys Res Commun"},{"issue":"11","key":"B138","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1158\/1535-7163.MCT-11-0758","article-title":"Selective targeting of interferon gamma to stromal fibroblasts and pericytes as a novel therapeutic approach to inhibit angiogenesis and tumor growth","volume":"11","author":"Bansal","year":"2012","journal-title":"Mol Cancer Ther"},{"issue":"10","key":"B139","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1101\/gad.1653708","article-title":"Role of platelet-derived growth factors in physiology and medicine","volume":"22","author":"Andrae","year":"2008","journal-title":"Genes Dev"},{"issue":"4","key":"B140","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.cytogfr.2004.03.006","article-title":"Regulation of PDGF and its receptors in fibrotic diseases","volume":"15","author":"Bonner","year":"2004","journal-title":"Cytokine Growth Factor Rev"},{"issue":"3","key":"B141","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1159\/000218708","article-title":"Role of stromal fibroblasts in cancer: promoting or impeding?","volume":"30","author":"Angeli","year":"2009","journal-title":"Tumour Biol"},{"issue":"11","key":"B142","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/nrc1477","article-title":"Friends or foes \u2013 bipolar effects of the tumour stroma in cancer","volume":"4","author":"Mueller","year":"2004","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"B143","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jconrel.2010.03.018","article-title":"A novel approach to deliver anticancer drugs to key cell types in tumors using a PDGF receptor-binding cyclic peptide containing carrier","volume":"145","author":"Prakash","year":"2010","journal-title":"J Control Release"}],"container-title":["Frontiers in Medicine"],"original-title":[],"deposited":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T01:49:54Z","timestamp":1692064194000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/Article\/10.3389\/fmed.2015.00072\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,5]]},"references-count":143,"URL":"https:\/\/doi.org\/10.3389\/fmed.2015.00072","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,5]]}}}